Two Sigma Securities’s Biolase BIOL Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOL
Two Sigma Securities's BIOL Position: Q3 2023 in Review
Two Sigma Securities sold out of Biolase (BIOL) in Q3 2023, closing a stake of 1,609 shares — an estimated $11.4K sold.
Two Sigma Securities first reported a position in BIOL in Q1 2016 and held it in 9 quarters. The position peaked at $20K in Q3 2017. 12 funds tracked by Wall St. Rank hold BIOL as of Q3 2023.
- Two Sigma Securities reported no remaining Biolase position as of Q3 2023 after selling out during the quarter.
- Two Sigma Securities sold 1,609 Biolase shares in Q3 2023, an estimated $11.4K.
- Two Sigma Securities first reported a position in Biolase in Q1 2016 and held it in 9 quarters.
- Two Sigma Securities's Biolase position peaked at $20K in Q3 2017.
- 12 funds tracked by Wall St. Rank held Biolase as of Q3 2023.
Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.